COUP-TFI modifies CXCL12 and CXCR4 expression by activating EGF signaling and stimulates breast cancer cell migration

详细信息    查看全文

• 作者：Antoine Boudot (12) (8)
  Gwenneg Kerdivel (8)
  Sylvain Lecomte (8)
  Gilles Flouriot (8)
  Mireille Desille (10) (9)
  Florence Godey (9)
  Jean Leveque (9)
  Patrick Tas (9)
  Yves Le Dr茅an (8)
  Farzad Pakdel (11) (8)
  
  12. Tufts Medical Center ; Tufts University School of Medicine ; Boston ; MA ; USA
  8. Institut de Recherche en Sant茅-Environnement-Travail (IRSET) ; INSERM U1085 ; Universit茅 de Rennes 1 ; Equipe TREC ; Biosit ; Rennes ; France
  10. Inserm ; UMR991 ; Foie ; M茅tabolismes et Cancer ; F-35033 ; Rennes ; France
  9. CHU Rennes ; CRLCC Eug猫ne Marquis et Centre de Ressources Biologiques-Sant茅 ; F-35033 ; Rennes ; France
  11. INSERM U1085 ; IRSET ; University of Rennes 1 ; Beaulieu Campus ; 35042 ; Rennes cedex ; France
  
• 关键词：COUP ; TF ; CXCL12 signaling ; Estrogen receptor ; Cell migration ; Breast cancer
• 刊名：BMC Cancer
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：14
• 期：1
• 全文大小：712 KB
• 参考文献：1. Barone, I, Brusco, L, Fuqua, SAW (2010) Estrogen receptor mutations and changes in downstream gene expression and signaling. Clin Cancer Res Off J Am Assoc Cancer Res 16: pp. 2702-2708 2.CCR-09-1753" target="_blank" title="It opens in new window">CrossRef
  2. Rochefort, H, Platet, N, Hayashido, Y, Derocq, D, Lucas, A, Cunat, S, Garcia, M (1998) Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview. J Steroid Biochem Mol Biol 65: pp. 163-168 CrossRef
  3. Platet, N, Cunat, S, Chalbos, D, Rochefort, H, Garcia, M (2000) Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms. Mol Endocrinol Baltim Md 14: pp. 999-1009 210/mend.14.7.0492" target="_blank" title="It opens in new window">CrossRef
  4. Kerdivel, G, Flouriot, G, Pakdel, F (2013) Modulation of estrogen receptor alpha activity and expression during breast cancer progression. Vitam Horm 93: pp. 135-160 2-416673-8.00004-6" target="_blank" title="It opens in new window">CrossRef
  5. Platet, N, Cathiard, AM, Gleizes, M, Garcia, M (2004) Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 51: pp. 55-67 2004.02.001" target="_blank" title="It opens in new window">CrossRef
  6. Kim, JJ, Kurita, T, Bulun, SE (2013) Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev 34: pp. 130-162 210/er.2012-1043" target="_blank" title="It opens in new window">CrossRef
  7. Pegram, MD, Konecny, G, Slamon, DJ (2000) The molecular and cellular biology of HER2/neu gene amplification/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer. Cancer Treat Res 103: pp. 57-75 CrossRef
  8. M茅tivier, R, Gay, FA, H\眉bner, MR, Flouriot, G, Salbert, G, Gannon, F, Kah, O, Pakdel, F (2002) Formation of an hER$\alpha$鈥揅OUP-TFI complex enhances hER$\alpha$ AF-1 through Ser118 phosphorylation by MAPK. EMBO J 21: pp. 3443-3453 CrossRef
  9. Le Dily, F, M茅tivier, R, Gu茅guen, M-M, Le P茅ron, C, Flouriot, G, Tas, P, Pakdel, F (2007) COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells. Breast Cancer Res Treat 110: pp. 69-83 CrossRef
  10. Park, J-I, Tsai, SY, Tsai, M-J (2003) Molecular mechanism of chicken ovalbumin upstream promoter-transcription factor (COUP-TF) actions. Keio J Med 52: pp. 174-181 2302/kjm.52.174" target="_blank" title="It opens in new window">CrossRef
  11. Boudot, A, Le Dily, F, Pakdel, F (2011) Involvement of COUP-TFs in Cancer Progression. Cancers 3: pp. 700-715 CrossRef
  12. Nagasaki, S, Suzuki, T, Miki, Y, Akahira, J, Shibata, H, Ishida, T, Ohuchi, N, Sasano, H (2009) Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma: Possible regulator of lymphangiogenesis via vascular endothelial growth factor-C expression. Cancer Sci 100: pp. 639-645 2008.01078.x" target="_blank" title="It opens in new window">CrossRef
  13. Qin, J, Wu, S-P, Creighton, CJ, Dai, F, Xie, X, Cheng, C-M, Frolov, A, Ayala, G, Lin, X, Feng, X-H, Ittmann, MM, Tsai, S-J, Tsai, M-J, Tsai, SY (2013) COUP-TFII inhibits TGF-尾-induced growth barrier to promote prostate tumorigenesis. Nature 493: pp. 236-240 CrossRef
  14. Hawkins, SM, Loomans, HA, Wan, YW, Ghosh-Choudhury, T, Coffey, D, Xiao, W, Liu, Z, Sangi-Haghpeykar, H, Anderson, ML (2013) Expression of COUP-TFII in epithelial ovarian cancers. J Clin Endocrinol Metab 98: pp. E1152-E1162 210/jc.2013-1081" target="_blank" title="It opens in new window">CrossRef
  15. Sun, X, Cheng, G, Hao, M, Zheng, J, Zhou, X, Zhang, J, Taichman, RS, Pienta, KJ, Wang, J (2010) CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev 29: pp. 709-722 256-x" target="_blank" title="It opens in new window">CrossRef
  16. Luker, KE, Luker, GD (2006) Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 238: pp. 30-41 2005.06.021" target="_blank" title="It opens in new window">CrossRef
  17. M\眉ller, A, Homey, B, Soto, H, Ge, N, Catron, D, Buchanan, ME, McClanahan, T, Murphy, E, Yuan, W, Wagner, SN, Barrera, JL, Mohar, A, Ver谩stegui, E, Zlotnik, A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410: pp. 50-56 CrossRef
  18. Kang, H, Watkins, G, Parr, C, Douglas-Jones, A, Mansel, RE, Jiang, WG (2005) Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Res 7: pp. R402-R410 22" target="_blank" title="It opens in new window">CrossRef
  19. Burger, JA, Kipps, TJ (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107: pp. 1761-1767 2/blood-2005-08-3182" target="_blank" title="It opens in new window">CrossRef
  20. Wendt, MK, Cooper, AN, Dwinell, MB (2008) Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells. Oncogene 27: pp. 1461-1471 210751" target="_blank" title="It opens in new window">CrossRef
  21. Zhou, W, Jiang, Z, Liu, N, Xu, F, Wen, P, Liu, Y, Zhong, W, Song, X, Chang, X, Zhang, X, Wei, G, Yu, J (2009) Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas. J Cancer Res Clin Oncol 135: pp. 91-102 2-008-0435-x" target="_blank" title="It opens in new window">CrossRef
  22. Wendt, MK, Johanesen, PA, Kang-Decker, N, Binion, DG, Shah, V, Dwinell, MB (2006) Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene 25: pp. 4986-4997 209505" target="_blank" title="It opens in new window">CrossRef
  23. Boudot, A, Kerdivel, G, Habauzit, D, Eeckhoute, J, Le Dily, F, Flouriot, G, Samson, M, Pakdel, F (2011) Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells. PLoS One 6: pp. e20898 20898" target="_blank" title="It opens in new window">CrossRef
  24. Vandesompele, J, De Preter, K, Pattyn, F, Poppe, B, Van Roy, N, De Paepe, A, Speleman, F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: pp. RESEARCH0034 2002-3-7-research0034" target="_blank" title="It opens in new window">CrossRef
  25. Eeckhoute, J, Lupien, M, Meyer, CA, Verzi, MP, Shivdasani, RA, Liu, XS, Brown, M (2008) Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers. Genome Res 19: pp. 372-380 2.108" target="_blank" title="It opens in new window">CrossRef
  26. Kishimoto, H, Wang, Z, Bhat-Nakshatri, P, Chang, D, Clarke, R, Nakshatri, H (2005) The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1 (alpha)/CXCL12. Carcinogenesis 26: pp. 1706 CrossRef
  27. Mor茅, E, Fellner, T, Doppelmayr, H, Hauser-Kronberger, C, Dandachi, N, Obrist, P, Sandhofer, F, Paulweber, B (2003) Activation of the MAP kinase pathway induces chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) expression in human breast cancer cell lines. J Endocrinol 176: pp. 83-94 CrossRef
  28. Nagy, PL, Cleary, ML, Brown, PO, Lieb, JD (2003) Genomewide demarcation of RNA polymerase II transcription units revealed by physical fractionation of chromatin. Proc Natl Acad Sci U S A 100: pp. 6364-6369 CrossRef
  29. Petit, FG, M茅tivier, R, Valotaire, Y, Pakdel, F (1999) Synergism between a half-site and an imperfect estrogen-responsive element, and cooperation with COUP-TFI are required for estrogen receptor (ER) to achieve a maximal estrogen-stimulation of rainbow trout ER gene. Eur J Biochem FEBS 259: pp. 385-395 2-1327.1999.00072.x" target="_blank" title="It opens in new window">CrossRef
  30. Rahimi, M, George, J, Tang, C (2010) EGFR variant-mediated invasion by enhanced CXCR4 expression through transcriptional and post-translational mechanisms. Int J Cancer Int Cancer 126: pp. 1850-1860
  31. Burbach, JP, Lopes da Silva, S, Cox, JJ, Adan, RA, Cooney, AJ, Tsai, MJ, Tsai, SY (1994) Repression of estrogen-dependent stimulation of the oxytocin gene by chicken ovalbumin upstream promoter transcription factor I. J Biol Chem 269: pp. 15046-15053
  32. Liu, Y, Yang, N, Teng, CT (1993) COUP-TF acts as a competitive repressor for estrogen receptor-mediated activation of the mouse lactoferrin gene. Mol Cell Biol 13: pp. 1836-1846
  33. Lu, X, Kang, Y (2010) Epidermal growth factor signalling and bone metastasis. Br J Cancer 102: pp. 457-461 CrossRef
  34. Foley, J, Nickerson, NK, Nam, S, Allen, KT, Gilmore, JL, Nephew, KP, Riese, DJ (2010) EGFR signaling in breast cancer: bad to the bone. Semin Cell Dev Biol 21: pp. 951-960 2010.08.009" target="_blank" title="It opens in new window">CrossRef
  35. Nakayama, T, Mutsuga, N, Tosato, G (2007) FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc. Blood 109: pp. 1363-1372 2/blood-2006-06-028217" target="_blank" title="It opens in new window">CrossRef
  36. Nakayama, T, Mutsuga, N, Tosato, G (2007) Effect of fibroblast growth factor 2 on stromal cell-derived factor 1 production by bone marrow stromal cells and hematopoiesis. J Natl Cancer Inst 99: pp. 223-235 CrossRef
  37. Wright, N, de Lera, TL, Garc铆a-Moruja, C, Lillo, R, Garc铆a-S谩nchez, F, Caruz, A, Teixid贸, J (2003) Transforming growth factor-beta1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion. Blood 102: pp. 1978-1984 2/blood-2002-10-3190" target="_blank" title="It opens in new window">CrossRef
  38. Grandis, JR, Sok, JC (2004) Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacol Ther 102: pp. 37-46 2004.01.002" target="_blank" title="It opens in new window">CrossRef
  39. Uchida, D, Onoue, T, Kuribayashi, N, Tomizuka, Y, Tamatani, T, Nagai, H, Miyamoto, Y (2011) Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases. Eur J Cancer Oxf Engl 1990 47: pp. 452-459
  40. Chen, G, Wang, Z, Liu, X, Liu, F (2011) High-level CXCR4 expression correlates with brain-specific metastasis of non-small cell lung cancer. World J Surg 35: pp. 56-61 268-010-0784-x" target="_blank" title="It opens in new window">CrossRef
  41. Furusato, B, Mohamed, A, Uhl茅n, M, Rhim, JS (2010) CXCR4 and cancer. Pathol Int 60: pp. 497-505 27.2010.02548.x" target="_blank" title="It opens in new window">CrossRef
  42. Zabel, BA, Wang, Y, Lew茅n, S, Berahovich, RD, Penfold, MET, Zhang, P, Powers, J, Summers, BC, Miao, Z, Zhao, B, Jalili, A, Janowska-Wieczorek, A, Jaen, JC, Schall, TJ (2009) Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol Baltim Md 1950 183: pp. 3204-3211
  43. Christopher, MJ, Liu, F, Hilton, MJ, Long, F, Link, DC (2009) Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. Blood 114: pp. 1331-1339 2/blood-2008-10-184754" target="_blank" title="It opens in new window">CrossRef
  44. Calonge, MJ, Seoane, J, Massagu茅, J (2004) Opposite Smad and chicken ovalbumin upstream promoter transcription factor inputs in the regulation of the collagen VII gene promoter by transforming growth factor-beta. J Biol Chem 279: pp. 23759-23765 2178200" target="_blank" title="It opens in new window">CrossRef
  45. Connor, H, Nornes, H, Neuman, T (1995) Expression screening reveals an orphan receptor chick ovalbumin upstream promoter transcription factor I as a regulator of neurite/substrate-cell contacts and cell aggregation. J Biol Chem 270: pp. 15066-15070 270.25.15066" target="_blank" title="It opens in new window">CrossRef
  46. Pradet-Balade, B, Boulm茅, F, Beug, H, M眉llner, EW, Garcia-Sanz, JA (2001) Translation control: bridging the gap between genomics and proteomics?. Trends Biochem Sci 26: pp. 225-229 CrossRef
  47. The pre-publication history for this paper can be accessed here: 2407/14/407/prepub" class="a-plus-plus">http://www.biomedcentral.com/1471-2407/14/407/prepub
  
• 刊物主题：Cancer Research; Oncology; Stem Cells; Animal Models; Internal Medicine;
• 出版者：BioMed Central
• ISSN：1471-2407

文摘

Background The orphan receptors COUP-TF (chicken ovalbumin upstream promoter transcription factor) I and II are members of the nuclear receptor superfamily that play distinct and critical roles in vertebrate organogenesis. The involvement of COUP-TFs in cancer development has recently been suggested by several studies but remains poorly understood. Methods MCF-7 breast cancer cells overexpressing COUP-TFI and human breast tumors were used to investigate the role of COUP-TFI in the regulation of CXCL12/CXCR4 signaling axis in relation to cell growth and migration. We used Immunofluorescence, western-blot, RT-PCR, Formaldehyde-assisted Isolation of Regulatory Elements (FAIRE) assays, as well as cell proliferation and migration assays. Results Previously, we showed that COUP-TFI expression is enhanced in breast cancer compared to normal tissue. Here, we report that the CXCL12/CXCR4 signaling pathway, a crucial pathway in cell growth and migration, is an endogenous target of COUP-TFI in breast cancer cells. The overexpression of COUP-TFI in MCF-7 cells inhibits the expression of the chemokine CXCL12 and markedly enhances the expression of its receptor, CXCR4. Our results demonstrate that the modification of CXCL12/CXCR4 expression by COUP-TFI is mediated by the activation of epithelial growth factor (EGF) and the EGF receptor. Furthermore, we provide evidence that these effects of COUP-TFI increase the growth and motility of MCF-7 cells in response to CXCL12. Cell migration toward a CXCL12 gradient was inhibited by AMD3100, a specific antagonist of CXCR4, or in the presence of excess CXCL12 in the cell culture medium. The expression profiles of CXCR4, CXCR7, CXCL12, and COUP-TFI mRNA in 82 breast tumors and control non-tumor samples were measured using real-time PCR. CXCR4 expression was found to be significantly increased in the tumors and correlated with the tumor grade, whereas the expression of CXCL12 was significantly decreased in the tumors compared with the healthy samples. Significantly higher COUP-TFI mRNA expression was also detected in grade 1 tumors. Conclusions Together, our mechanistic in vitro assays and in vivo results suggest that a reduction in chemokine CXCL12 expression, with an enhancement of CXCR4 expression, provoked by COUP-TFI, could be associated with an increase in the invasive potential of breast cancer cells.